zika
viru
zikv
emerg
mosquitoborn
flaviviru
transmit
differ
aed
mosquito
speci
includ
aed
aegypti
zikv
tropism
variou
addit
skin
fibroblast
epiderm
keratinocyt
dendrit
cell
dc
found
permiss
infect
zikv
origin
identifi
uganda
year
limit
zikv
outbreak
report
especi
pacif
island
phylogenet
studi
reveal
zika
viru
evolv
distinct
genotyp
west
african
nigerian
cluster
east
african
prototyp
cluster
asian
largest
zikv
epidem
begun
brazil
spread
throughout
america
infect
nearli
two
million
peopl
viru
caus
epidem
found
close
relat
isol
french
polynesia
within
asian
clade
although
zikvassoci
ill
initi
describ
selflimit
mild
ill
character
rash
fever
conjunct
arthralgia
arthriti
gener
accept
zikv
respons
neurolog
birth
defect
includ
microcephali
newborn
innat
immun
respons
particular
interferon
ifn
system
play
key
role
orchestr
protect
flavivirus
infect
howev
role
innat
immun
respons
zikv
infect
controversi
studi
report
abil
placent
macrophag
primari
human
trophoblast
limit
zikv
infect
produc
type
iii
especi
ifn
respect
furthermor
shown
exposur
primari
human
fibroblast
zikv
trigger
respons
accompani
activ
type
ifn
signal
pathway
express
sever
antivir
gene
contrari
kumar
colleagu
observ
strong
suppress
ifn
isg
express
zikvinfect
cell
vitro
signific
reduct
type
type
iii
ifn
signal
addit
inhibit
type
ifn
protein
translat
observ
zikv
infect
dc
despit
induct
transcript
level
furthermor
treatment
human
dc
retino
acidinduc
gene
rigi
agonist
shown
potent
restrict
zikv
replic
type
ifn
modest
effect
recent
studi
mammal
cell
demonstr
zikv
protein
abl
activ
select
manner
opposit
effect
type
iii
ifn
name
suppress
activ
therefor
select
activ
signal
zikv
might
also
impact
immun
function
macrophag
activ
respons
moreov
aberr
activ
innat
immun
observ
acut
phase
zikvinfect
patient
lead
cytokin
profil
associ
nonsignificantli
also
respons
particular
modul
role
antivir
immun
suggest
human
viral
infect
associ
elev
level
sever
acut
respiratori
syncyti
viru
infect
nonrespons
treatment
chronic
hepat
c
describ
date
infect
differ
african
contemporari
asian
lineag
scarc
investig
current
outbreak
spur
research
toward
better
understand
zikv
infect
affect
host
immun
respons
studi
evalu
effect
asian
genbank
east
african
genbank
zikv
strain
infect
induct
ifn
proinflammatori
cytokin
human
pbmc
vero
cell
number
maintain
modifi
eagl
medium
mem
supplement
heatinactiv
fetal
calf
serum
fc
humidifi
atmospher
viru
stock
prepar
vero
cell
infect
zikv
strain
provid
european
viru
archiv
evag
isol
genbank
access
number
obtain
travel
return
brazil
januari
cell
lysat
clarifi
aliquot
store
use
viru
titrat
perform
vero
cell
line
limit
dilut
assay
titer
calcul
use
method
reed
muench
express
tissu
cultur
infecti
dose
viru
stock
titer
pbmc
obtain
healthi
donor
ficollhypaqu
pharmacia
sweden
densiti
centrifug
cultur
perform
rpmi
medium
gibco
usa
contain
heatinactiv
fc
pbmc
donor
use
infect
experi
experi
fresh
pbmc
expos
either
hour
differ
multipl
infect
moi
rang
end
adsorpt
period
pbmc
wash
reseed
cellsml
rpmi
fc
incub
hour
postinfect
hpi
supernat
cell
collect
store
subsequ
analysi
assess
viral
replic
total
rna
extract
cell
trizol
life
technolog
ny
usa
accord
manufactur
protocol
zikv
rna
amplifi
use
realtim
realstar
zika
viru
rtpcr
kit
altona
diagnost
hamburg
germani
rotorgen
q
realtim
cycler
releas
pbmc
supernat
measur
enzymelink
immunosorb
assay
elisa
name
verikineh
human
purchas
pbl
assay
scienc
piscataway
nj
usa
duoset
human
purchas
r
system
inc
minneapoli
mn
usa
result
express
pgml
detect
rang
pgml
pgml
posit
control
ifn
induct
newcastl
diseas
viru
ndv
use
experi
hemagglutin
unit
hu
cell
neg
control
cytokin
detect
pbmc
treat
medium
use
supernat
assay
use
multiplex
beadbas
assay
bioplex
pro
human
group
low
limit
quantif
lloq
pgml
lloq
pgml
lloq
pgml
lloq
pgml
lloq
pgml
lloq
pgml
lloq
pgml
biorad
laboratori
ca
usa
plate
measur
use
bioplex
magpix
system
analyz
bioplex
manag
version
biorad
laboratori
ca
usa
result
express
median
statist
signific
assess
u
test
use
graphpad
prism
graphpad
softwar
inc
la
jolla
ca
usa
p
consid
statist
signific
institut
ethic
board
inmi
approv
use
pbmc
collect
healthi
donor
research
purpos
healthi
donor
sign
specif
inform
consent
singl
procedur
treatment
perform
thorough
explan
reason
anticip
benefit
potenti
hazard
intervent
public
research
studi
test
abil
zikv
induc
ifn
respons
human
pbmc
cell
healthi
donor
expos
differ
zikv
strain
either
east
african
contemporari
asian
moi
product
replic
zikv
strain
observ
ndv
use
posit
control
ifn
induct
case
strong
respons
observ
ndvexpos
pbmc
specif
ndv
induc
h
median
pgml
h
pgml
h
pgml
h
median
pgml
h
pgml
h
pgml
h
median
pgml
h
pgml
h
pgml
indic
good
induc
ifn
respons
experiment
condit
supernat
infect
pbmc
collect
differ
hpi
product
differ
ifn
type
assess
activ
either
type
iii
observ
exposur
either
zikv
strain
type
ii
ifn
show
although
signific
slight
increas
respons
infect
peak
hpi
figur
consid
none
fourth
donor
previou
contact
flaviviru
sinc
sera
test
indirect
immun
fluoresc
assay
ifa
zika
dengu
yellow
fever
detect
threshold
moreov
even
use
higher
moi
infect
pbmc
neither
evid
viral
replic
induct
ifn
system
observ
data
shown
evalu
abil
zikv
induc
inflammatori
respons
pbmc
cytokin
product
quantifi
challeng
zikv
strain
particular
inflammatori
antiinflammatori
cytokin
evalu
respons
either
zikv
strain
infect
figur
b
c
analysi
show
larg
variabl
mainli
hpi
transient
signific
induct
observ
hpi
exposur
figur
b
differ
induc
hpi
exposur
persist
hpi
notabl
signific
differ
detect
hpi
level
higher
respect
p
figur
b
level
respons
indic
signific
induct
infect
peak
h
infect
p
contrast
signific
upregul
protein
evidenc
follow
infect
figur
c
final
antiinflammatori
respons
observ
infect
figur
c
follow
recent
outbreak
rage
america
zikv
becom
emerg
arboviru
potenti
impact
human
health
support
declar
phc
februari
knowledg
limit
controversi
inform
avail
innat
host
immun
respons
develop
respons
zikv
infect
human
vectorborn
flavivirus
studi
far
need
overcom
type
ifn
signal
replic
caus
diseas
vertebr
mechan
zikv
interfer
innat
respons
object
intens
investig
still
fulli
understood
paper
analyz
abil
zikv
activ
immun
respons
human
pbmc
sinc
well
known
cell
repres
gatekeep
viru
spread
bodi
system
viral
infect
includ
sever
subpopul
may
cooper
activ
process
result
show
zikv
fail
induc
type
type
iii
ifn
abl
poorli
activ
type
ii
ifn
produc
proinflammatori
cytokin
particular
report
slight
modul
type
ii
ifn
pbmc
expos
strain
complet
lack
type
iiii
ifn
induct
strain
suggest
abil
zikv
evad
ifn
system
inhibit
antivir
ifn
respons
also
ifn
product
moreov
highlight
polyfunct
immun
activ
pbmc
expos
strain
due
induct
inflammatori
profil
respons
well
associ
acutephas
respons
repres
key
inflammatori
signal
induc
effect
immun
respons
respons
activ
cellular
compon
innat
respons
coordin
tlymphocyt
prolifer
nevertheless
dengu
infect
high
level
associ
severehemorrhag
infect
suggest
unbalanc
inflammatori
respons
may
particip
pathogenesi
diseas
note
recent
report
dengu
infect
coordin
balanc
proinflammatori
regulatori
signal
repres
key
protect
immun
respons
side
cytokin
produc
primarili
cell
gener
report
mediat
allerg
autoimmun
diseas
recent
studi
suggest
play
import
role
human
viral
infect
sever
acut
respiratori
syncyti
viru
infect
viral
myocard
role
modul
cell
immun
well
protect
andor
pathogenesi
viral
diseas
need
investig
observ
line
tapp
et
al
studi
report
upregul
inflammatori
cytokin
level
activ
type
ii
ifn
human
serum
sampl
acut
zikv
infect
particular
show
poor
increas
trend
acut
recoveri
phase
extend
knowledg
modul
immun
paramet
zikv
infect
moreov
experiment
condit
product
replic
observ
zikv
strain
even
use
high
moi
thu
suggest
membran
mechan
could
respons
ifn
cytokin
induct
previous
shown
virus
includ
hiv
hsv
sar
conclus
result
indic
neither
strain
abl
activ
effici
ifn
respons
except
poor
activ
type
ii
ifn
strain
moreov
induct
inflammatori
cytokin
observ
lack
activ
type
iii
ifn
respons
pbmc
may
reflect
escap
mechan
innat
immun
defens
may
exceed
presenc
acutephas
proinflammatori
cytokin
peculiar
behavior
may
pathogenet
implic
viru
spread
vivo
includ
mothertochild
transmiss
induct
sever
fetal
complic
birth
defect
neurolog
disord
investig
need
establish
link
observ
correct
activ
immun
system
zikv
infect
identifi
differ
intracellular
signal
induc
differ
zikv
strain
respons
differ
cytokin
respons
